TY - JOUR AU - Nogueira, Sonia Tereza Santos AU - Lima, Eduardo Nóbrega Pereira AU - Nóbrega, Amanda França AU - Torres, Ivone Do Carmo Gonçalves AU - Cavicchioli, Marcelo AU - Hainaut, Pierre AU - Achatz, Maria Isabel Waddington PY - 2015 M3 - Original Research TI - 18F-FDG PET-CT for Surveillance of Brazilian Patients with Li-Fraumeni Syndrome JO - Frontiers in Oncology UR - https://www.frontiersin.org/articles/10.3389/fonc.2015.00038 VL - 5 SN - 2234-943X N2 - Purpose: To evaluate the effectiveness of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting early cancer in carriers of germline TP53 mutation, the genetic defect underlying Li-Fraumeni and related syndromes, which predisposes to many forms of cancer throughout life.Patients and methods: A total of 30 adult patients from six families with germline TP53 mutations were recruited. These patients did not have a diagnosis of cancer in the 24 months preceding the study. Anomalous concentrations from whole-body 18F-FDG-PET/CT were assessed by two independent experts. Suspicious lesions were excised and subjected to pathological examination.Results: A total of 6/30 patients showed abnormal 18F-FDG-concentration. Confirmation studies revealed three cases of cancer, including one lung cancer, one ovarian cancer, and one disseminated breast cancer. Three patients had non-malignant lesions (one Bartholin’s cyst and two cases of reactive lymph nodes).Conclusion:18F-FDG-PET/CT is effective in detecting cancer in subjects who are asymptomatic according to current screening guidelines. These results further suggest that 18F-FDG-PET/CT is an appropriate method for surveillance of cancer risk in TP53 mutation carriers. ER -